Literature DB >> 8535642

Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?

H A Bird1.   

Abstract

Sulphasalazine is cleaved into 5-aminosalicylic acid and sulphapyridine by colonic bacteria. The bulk of evidence favours sulphapyridine rather than 5-aminosalicylic acid as the active moiety (as well as the main producer of side-effects) though a therapeutic action from the 30% of sulphasalazine that is absorbed unaltered also cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8535642

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  8 in total

1.  Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.

Authors:  C Wahl; S Liptay; G Adler; R M Schmid
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

2.  Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis.

Authors:  C J Haagsma; H J Blom; P L van Riel; M A van't Hof; B A Giesendorf; D van Oppenraaij-Emmerzaal; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1999-02       Impact factor: 19.103

3.  Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine.

Authors:  S Liptay; M Bachem; G Häcker; G Adler; K M Debatin; R M Schmid
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

Review 4.  Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis.

Authors:  Michael T Nurmohamed; Ben A C Dijkmans
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 5.  Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis.

Authors:  Alejandro Díaz-Borjón
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

6.  Investigation of mitigating effect of colon-specific prodrugs of boswellic acid on 2,4,6-trinitrobenzene sulfonic acid-induced colitis in Wistar rats: Design, kinetics and biological evaluation.

Authors:  Ajinkya Sarkate; Suneela S Dhaneshwar
Journal:  World J Gastroenterol       Date:  2017-02-21       Impact factor: 5.742

7.  Methotrexate and relative risk of dementia amongst patients with rheumatoid arthritis: a multi-national multi-database case-control study.

Authors:  Danielle Newby; Daniel Prieto-Alhambra; Talita Duarte-Salles; David Ansell; Lars Pedersen; Johan van der Lei; Mees Mosseveld; Peter Rijnbeek; Glen James; Myriam Alexander; Peter Egger; Jana Podhorna; Robert Stewart; Gayan Perera; Paul Avillach; Solène Grosdidier; Simon Lovestone; Alejo J Nevado-Holgado
Journal:  Alzheimers Res Ther       Date:  2020-04-06       Impact factor: 6.982

Review 8.  Clinically important drug interactions with disease-modifying antirheumatic drugs.

Authors:  C J Haagsma
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 4.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.